Epidermolysis Bullosa
Epidermolysis Bullosa Awareness Week: Achieving Positive Change Through Treatment Innovations and Emerging Therapies
This Epidermolysis Bullosa (EB) Awareness Week, we reflect on the
October 22, 2025
This Epidermolysis Bullosa (EB) Awareness Week, we reflect on the
In May 2023, the FDA approved beremagene geperpavec (B-VEC, Vyjuvek®),
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
